| A Bayesian neural network method for adverse drug reaction signal generation A Bate, M Lindquist, IR Edwards, S Olsson, R Orre, A Lansner, ... European journal of clinical pharmacology 54, 315-321, 1998 | 1152 | 1998 |
| A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions EP van Puijenbroek, A Bate, HGM Leufkens, M Lindquist, R Orre, ... Pharmacoepidemiology and drug safety 11 (1), 3-10, 2002 | 1016 | 2002 |
| Quantitative signal detection using spontaneous ADR reporting A Bate, SJW Evans Pharmacoepidemiology and drug safety 18 (6), 427-436, 2009 | 677 | 2009 |
| Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis EJ Sanz, C De-las-Cuevas, A Kiuru, A Bate, R Edwards The Lancet 365 (9458), 482-487, 2005 | 476 | 2005 |
| Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study DM Coulter, A Bate, RHB Meyboom, M Lindquist, IR Edwards Bmj 322 (7296), 1207-1209, 2001 | 372 | 2001 |
| A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database M Lindquist, M Stĺhl, A Bate, IR Edwards, RHB Meyboom Drug safety 23, 533-542, 2000 | 238 | 2000 |
| Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery GN Norén, J Hopstadius, A Bate Statistical methods in medical research 22 (1), 57-69, 2013 | 220 | 2013 |
| Temporal pattern discovery in longitudinal electronic patient records GN Norén, J Hopstadius, A Bate, K Star, IR Edwards Data Mining and Knowledge Discovery 20, 361-387, 2010 | 205 | 2010 |
| Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1. 0 IISTFRWEHCDM S. V. Wang, S. Schneeweiss Pharmacoepidemiology and Drug Safety 26 (9), 1018-1032, 2017 | 192* | 2017 |
| Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events GN Norén, A Bate, R Orre, IR Edwards Statistics in medicine 25 (21), 3740-3757, 2006 | 187 | 2006 |
| A data mining approach for signal detection and analysis A Bate, M Lindquist, IR Edwards, R Orre Drug safety 25, 393-397, 2002 | 181 | 2002 |
| Myocarditis related to clozapine treatment S Hägg, O Spigset, AB BAHons, TG Söderström Journal of clinical psychopharmacology 21 (4), 382, 2001 | 169 | 2001 |
| A statistical methodology for drug–drug interaction surveillance GN Norén, R Sundberg, A Bate, IR Edwards Statistics in medicine 27 (16), 3057-3070, 2008 | 166 | 2008 |
| Decision support methods for the detection of adverse events in post-marketing data M Hauben, A Bate Drug discovery today 14 (7-8), 343-357, 2009 | 159 | 2009 |
| Bayesian neural networks with confidence estimations applied to data mining R Orre, A Lansner, A Bate, M Lindquist Computational Statistics & Data Analysis 34 (4), 473-493, 2000 | 147 | 2000 |
| Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross‐national descriptive study from the PROTECT‐EU … C Huerta, V Abbing‐Karahagopian, G Requena, B Oliva, Y Alvarez, ... Pharmacoepidemiology and drug safety 25, 56-65, 2016 | 138 | 2016 |
| Disproportionality methods for pharmacovigilance in longitudinal observational databases I Zorych, D Madigan, P Ryan, A Bate Statistical methods in medical research 22 (1), 39-56, 2013 | 130 | 2013 |
| Duplicate detection in adverse drug reaction surveillance GN Norén, R Orre, A Bate, IR Edwards Data Mining and Knowledge Discovery 14, 305-328, 2007 | 129 | 2007 |
| Good signal detection practices: evidence from IMI PROTECT AFZ Wisniewski, A Bate, C Bousquet, A Brueckner, G Candore, K Juhlin, ... Drug safety 39, 469-490, 2016 | 120 | 2016 |
| From association to alert—a revised approach to international signal analysis M Lindquist, IR Edwards, A Bate, H Fucik, AM Nunes, M Stĺhl Pharmacoepidemiology and drug safety 8 (S1), S15-S25, 1999 | 117 | 1999 |
Marie LindquistDirector, Uppsala Monitoring CentreVerified email at who-umc.org
